IMMUNOSUPPRESSIVE TREATMENT OF HBSAG-POSITIVE CHRONIC LIVER-DISEASE - SIGNIFICANCE OF HBEAG

被引：6
作者：
TAGEJENSEN, U
ALDERSHVILE, J
SCHLICHTING, P
机构：
[1] KOMMUNE HOSP,DEPT MED 2,DK-1399 COPENHAGEN,DENMARK
[2] RIGSHOSP,DEPT MED A,DK-2100 COPENHAGEN O,DENMARK
[3] RIGSHOSP,DEPT INFECT DIS,DK-2100 COPENHAGEN O,DENMARK
[4] SKT ELISABETH HOSP,DEPT MED,COPENHAGEN,DENMARK
[5] HVIDOVRE HOSP,DIV HEPATOL,COPENHAGEN,DENMARK
[6] HVIDOVRE HOSP,DEPT PATHOL,COPENHAGEN,DENMARK
来源：
HEPATOLOGY | 1985年 / 5卷 / 01期
关键词：
D O I：
10.1002/hep.1840050111
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：47 / 49
页数：3
相关论文
共 50 条
  • [21] IMMUNOSUPPRESSIVE TREATMENT OF CHRONIC LIVER-DISEASE
    JONES, EA
    BERGASA, NV
    IMMUNOSUPPRESSIVE AND ANTIINFLAMMATORY DRUGS, 1993, 696 : 319 - 327
  • [22] TERMINATION OF IMMUNOSUPPRESSIVE THERAPY IN HBSAG-POSITIVE CHRONIC HEPATITIS
    HESS, G
    SLUSARCZYK, J
    ZUMBUSCHENFELDE, KHM
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1985, 23 (09): : 446 - 446
  • [23] TREATMENT OF HBSAG POSITIVE CHRONIC LIVER-DISEASE WITH ADENINE-ARABINOSIDE
    BASSENDINE, MF
    CHADWICK, RG
    SALMERON, J
    SHIPTON, U
    THOMAS, HC
    SHERLOCK, S
    GUT, 1979, 20 (10) : A906 - A907
  • [24] SIGNIFICANCE OF MEMBRANOUS HBSAG POSITIVITY IN CHRONIC LIVER-DISEASE
    BUSACHI, CA
    GARDELLI, T
    BADIALIDEGIORGI, L
    LENZI, M
    LANDI, P
    BIANCHI, FB
    LASCHI, R
    PISI, E
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1979, 11 (04): : 177 - 180
  • [25] SIGNIFICANCE OF MEMBRANOUS HBSAG POSITIVITY IN CHRONIC LIVER-DISEASE
    BUSACHI, CA
    GARDELLI, T
    DEGIORGI, LB
    LENZI, M
    LANDI, P
    BIANCHI, FB
    LASCHI, R
    PISI, E
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1980, 12 (01): : 48 - 48
  • [26] LEVELS OF LYMPHOCYTE ADENOSINE-DEAMINASE IN ACTIVE AND INACTIVE FORMS OF HBSAG-POSITIVE CHRONIC LIVER-DISEASE
    NARDIELLO, S
    PIZZELLA, T
    TARANTINO, L
    RUSSO, M
    GALANTI, B
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1982, 20 (06): : 398 - 398
  • [27] HCV INFECTION IN HBSAG POSITIVE CHRONIC LIVER-DISEASE
    FATUZZO, F
    MUGHINI, MT
    CACOPARDO, B
    LAROSA, R
    NIGRO, L
    LUPO, G
    BRUNO, S
    ZUCCARELLO, M
    CALTABIANO, E
    ZIPPER, F
    COSENTINO, S
    RUSSO, R
    NUNNARI, A
    ARCHIVES OF VIROLOGY, 1992, : 325 - 326
  • [28] ANTIVIRAL THERAPY IN HBSAG-POSITIVE CHRONIC LIVER-DISEASE (HBSAG+VE CLD) - HOW MANY PATIENTS REALLY NEED IT
    ASCIONE, A
    AMITRANO, L
    RICCIO, E
    DELELLA, A
    CANESTRINI, C
    DEBELLIS, G
    DALESSANDRO, R
    FIORE, R
    PADULANO, P
    HEPATO-GASTROENTEROLOGY, 1984, 31 (03) : 123 - 124
  • [29] HEPATITIS-D VIRUS-ANTIBODY IN HBSAG-POSITIVE AND HBSAG-NEGATIVE SUBSTANCE ABUSERS WITH CHRONIC LIVER-DISEASE
    NOVICK, DM
    FARCI, P
    KARAYIANNIS, P
    GELB, AM
    STENGER, RJ
    KREEK, MJ
    THOMAS, HC
    JOURNAL OF MEDICAL VIROLOGY, 1985, 15 (04) : 351 - 356
  • [30] TREATMENT OF HBSAG POSITIVE CHRONIC LIVER-DISEASE WITH BACILLUS CALMETTE GUERIN (BCG)
    BASSENDINE, MF
    WELLER, IVD
    MURRAY, A
    SUMMERS, J
    THOMAS, HC
    SHERLOCK, S
    GUT, 1980, 21 (10) : A915 - A915
12345